Home | Nanoparticle drug delivery research gets a boost
Editor's letter
Contents
Mimotopes Company Insight
Mimotopes
Briefing
News in Numbers
Latest News
Latest Deals
Project Updates
Nipro
In Depth
Covid-19 vaccine success bolsters nanoparticle drug delivery research
eConsent in clinical trials: What’s on the horizon?
Breathing easy: How digital inhalers are changing asthma treatment
Primate models in pharma: What the future holds
A decade on, what’s next for CAR-T therapies?
FDA’s $7bn plan for 2024: Disclose CMOs, restart Cancer Moonshot
Molnar-Institute Company Insight
Molnar-Institute
Thematic Take
Thematic Take: contents
Foreword
ESG is the most important theme of this decade
A timeline of corporate ESG
The most pressing ESG concerns for the pharma industry
Key trends impacting ESG performance in the healthcare sector
Latest news: ESG in pharma
Sustainable supply chains: Clinical trials in a new era of limited resources
Increase in DPI use could lead to decreases in greenhouse gas emissions
Environmental sustainability innovation: Leading companies in anti-malarial compositions
Deal activity related to ESG in the pharmaceutical industry since 2020
ESG hiring trends in the global pharmaceutical industry since 2020
ESG patent applications in the global pharmaceutical industry since 2020
Mentions of ESG in pharmaceutical industry company filings since 2020
GlobalData Thematic Intelligence
Pharma Sponsored Supplements
CfPIE
Listings
Events
Rankings
Buyer's Guides
Next issue
04/27/2023 00:00:00
Go to article:
Home | Nanoparticle drug delivery research gets a boost
Go to article:
Editor's letter
Go to article:
Contents
Go to article:
Mimotopes Company Insight
Go to article:
Mimotopes
Go to article:
Briefing
Go to article:
News in Numbers
Go to article:
Latest News
Go to article:
Latest Deals
Go to article:
Project Updates
Go to article:
Nipro
Go to article:
In Depth
Go to article:
Covid-19 vaccine success bolsters nanoparticle drug delivery research
Go to article:
eConsent in clinical trials: What’s on the horizon?
Go to article:
Breathing easy: How digital inhalers are changing asthma treatment
Go to article:
Primate models in pharma: What the future holds
Go to article:
A decade on, what’s next for CAR-T therapies?
Go to article:
FDA’s $7bn plan for 2024: Disclose CMOs, restart Cancer Moonshot
Go to article:
Molnar-Institute Company Insight
Go to article:
Molnar-Institute
Go to article:
Thematic Take
Go to article:
Thematic Take: contents
Go to article:
Foreword
Go to article:
ESG is the most important theme of this decade
Go to article:
A timeline of corporate ESG
Go to article:
The most pressing ESG concerns for the pharma industry
Go to article:
Key trends impacting ESG performance in the healthcare sector
Go to article:
Latest news: ESG in pharma
Go to article:
Sustainable supply chains: Clinical trials in a new era of limited resources
Go to article:
Increase in DPI use could lead to decreases in greenhouse gas emissions
Go to article:
Environmental sustainability innovation: Leading companies in anti-malarial compositions
Go to article:
Deal activity related to ESG in the pharmaceutical industry since 2020
Go to article:
ESG hiring trends in the global pharmaceutical industry since 2020
Go to article:
ESG patent applications in the global pharmaceutical industry since 2020
Go to article:
Mentions of ESG in pharmaceutical industry company filings since 2020
Go to article:
GlobalData Thematic Intelligence
Go to article:
Pharma Sponsored Supplements
Go to article:
CfPIE
Go to article:
Listings
Go to article:
Events
Go to article:
Rankings
Go to article:
Buyer's Guides
Go to article:
Next issue